Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06647238 · ClinicalTrials.gov registry record · NA
Evaluation of Pharmacist Interventions in Lipid Management for Secondary Prevention
A NA study of Coronary Artery Disease and Hyperlipidemia, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06647238 is a NA study of Coronary Artery Disease and Hyperlipidemia that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 80 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06647238, a NA study of Coronary Artery Disease and Hyperlipidemia, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this research project is to compare the effect of pharmacist interventions versus usual care in the implementation of guideline directed lipid lowering therapies for secondary prevention.
Conditions Studied
Interventions
- OTHER Pharmacist Intervention in lipid therapy
Study Locations (1)
North Carolina
- Atrium Health Cabarrus - Concord
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-11-05 |
| Est. Completion | 2025-05-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06647238
The ClinicalTrials.gov registry entry for NCT06647238 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (94% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Pharmacist Intervention in lipid therapy is the first listed.
NCT06647238 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06647238 about?
NCT06647238 is a clinical study titled "Evaluation of Pharmacist Interventions in Lipid Management for Secondary Prevention". The primary objective of this research project is to compare the effect of pharmacist interventions versus usual care in the implementation of guideline directed lipid lowering therapies for secondary prevention.
What is the current status of trial NCT06647238?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2024-11-05. Estimated completion is 2025-05-27.
What conditions does trial NCT06647238 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Hyperlipidemia.
What interventions are being tested in trial NCT06647238?
The interventions under investigation include: Pharmacist Intervention in lipid therapy (OTHER).
Who is sponsoring clinical trial NCT06647238?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06647238 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
-
Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.